Pharmacology and clinical applications of botulinum toxins A and B.
Thakker
Manoj M
MM
Massachusetts Eye and Ear Infirmary, Harvard Medical School, 243 Charles Street, Boston, MA 02114, USA.
Rubin
Peter A D
PA
D001905:Botulinum Toxins / Q000494:pharmacology* / Q000627:therapeutic use; D019274:Botulinum Toxins, Type A / Q000494:pharmacology* / Q000627:therapeutic use; D000075202:Contraindications; D017277:Drug Approval; D006801:Humans; D009465:Neuromuscular Agents / Q000494:pharmacology* / Q000627:therapeutic use; D015835:Ocular Motility Disorders / Q000188:drug therapy; D014481:United States; D014486:United States Food and Drug Administration
D009465:Neuromuscular Agents; C096323:rimabotulinumtoxinB; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A